CEU: Psychopharmacology - Module 6: Ethics of Medication
You could be the first person to provide your opinion.
Purchase now & provide your feedback on this product and receive a $25 store credit!
Ms. Manya Ralkowski has been practicing in the field of applied behavior analysis for over 25 years. Her training began under direct education and training from consultants from the Lovaas Clinic in Los Angeles while completing her bachelor of arts in Communication Disorders with endorsements in special education and psychology at Western Washington University. Ms. Ralkowski continued her education and training with a master’s degree in Education from Lesley University and a graduate certificate in Applied Behavior Analysis from the University of Washington while working as an assistant teacher on the Project DATA grant at the Haring Center-Professional Training Unit. She also possesses a doctorate degree in Instructional Leadership.
Dr. Ronald Brown, a noted expert on the topic of ADHD has served as the Associate Vice Chancellor for Academic (Health Affairs) at the University of North Texas System.
Dr. Brown completed his Ph.D. from Georgia State University and has been the past President of the Society of Pediatric Psychology and the Association of Psychologists of Academic Health Centers.
He is a board-certified clinical health psychologist and has been an active clinician, teacher, advocate and investigator. He served as a member of the Behavioral Medicine study section of the NIH and chaired several special panels at NIH. He currently serves as the Editor of Professional Psychology: Research and Practice.
Dr. Ronald Brown’s area of specialization includes behavioral sciences, pediatric psychology, attention deficit disorders, neuropsychology, psychopharmacology, learning disabilities and psychosocial oncology.
Dr. Debbie Coehlo is a certified Pediatric Nurse Practitioner and Pediatric Mental Health Specialist with a Doctoral Degree in Family Sciences and Human Development. She is the Founder and Director of Juniper Pediatrics, a clinic modeled after John F Kennedy’s multidisciplinary system of care. Using a holistic, integrated care model, Juniper provides counseling, medication management and family therapy for children with ASD, ADHD and other childhood mental health disorders.
Dr. Coehlo completed her Master’s in Nursing with a specialty in parent- child nursing. She spent 10 years working at the Child Development Center at the University of Washington in the Genetics Clinic and Multidisciplinary Clinic. In 1999, she complete her Doctorate degree in Human Development and Family Studies.
She continues to teach at the undergraduate and graduate level and had pursued research in the area of social networking, transitioning to out of home care for families, and child development.
Dr. Coehlo is a co- editor for the 4th and 5th edition of Family Health Nursing (F.A. Dais, 2010/2013) and has published several journal articles in the areas of families choosing residential care, families in transition, family health nursing, and care of children with special health care needs.
BCBA CEUs: 2 BACB General
QABA CEUs: 2 General
IBAO CEUs: 2 General
APA/CESA: 2 General (Home Study)
In our webinar on Psychopharmacology and the Ethics of Medication, we focused on the ethical dilemmas facing families and providers when considering psychotropic medications for children. We reviewed the four ethical principles, including respect for autonomy, beneficence, non-maleficence, and justice, and how these principles apply to using psychotropic medications with children.
Presenters: Ronald T. Brown, Ph.D., ABPP, and Deborah P. Coehlo, Ph.D., C-PNP, PMHS, CFLE
Panelist: Manya Ralkowski, EdS, BCBA, LBA, IBA
Learning Objectives:
1. Review the reasons for more children being prescribed psychotropic medications in the US, including increased diagnosis of treatable conditions, increased access to safe medications, and increased trauma-related disorders in children.
2. Explore and discuss the four ethical principles and how they apply to prescribing psychotropic medications in children.
3. Evaluate societal and cultural factors that may influence whether medications are used to treat mental health disorders in children.
4. Analyze concerns regarding the use of psychotropic medications in children, including over-prescribing, failure to consider behavioral approaches when indicated, polypharmacy, and inappropriate use of “off-label” medications.
5. Apply knowledge to specific case studies including assessment, diagnosis, treatment, and evaluation of outcomes.
6. Examine approaches used to discuss ethical principles related to prescribing medications to parents of children with mental health disorders.
TIMELINE: This course, on its own has a license for active use for 30 days unless it is purchased as part of a bundle/library.
MANDATORY DISCLAIMER: The Behavior Analyst Certification Board (“BACB”) does not sponsor, approve, or endorse Special Learning, the materials, information, or sessions identified herein.
NOTE: CEs claimed on any training completed can only be claimed once. If you repeat training you’ve already claimed CEs on, you won’t be able to claim the CEs again. Please ensure you have not already completed and claimed the CEs for the training module before purchase. Want to customize your training? You can build your own CE library HERE. For cancellations and refunds, please see our return policy.
No reviews yet!
For adding a review for this product you need to purchase current product and be authorized.